Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-21-003293
Filing Date
2021-10-28
Accepted
2021-10-28 08:30:22
Documents
3
Period of Report
2021-10-28

Document Format Files

Seq Description Document Type Size
1 6-K zk2126709.htm 6-K 11391
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 17400
3 image0.jpg GRAPHIC 3051
  Complete submission text file 0001178913-21-003293.txt   34171
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38556 | Film No.: 211355169
SIC: 2836 Biological Products, (No Diagnostic Substances)